Skip to main content
Fig. 5 | Parasites & Vectors

Fig. 5

From: Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis

Fig. 5

Impact of annual mass drug administration (MDA) at 80 % coverage with supplemental vector control (VC) on the model-predicted community-level microfilariae (mf) prevalence of lymphatic filariasis (LF) for each study site. The supplemental VC was implemented at the population-level coverage of 80 %, and its effect was continued throughout the model simulation period, ie. even beyond the MDA stopping time-point indicated by the vertical lines. All other details as described in Fig. 4

Back to article page